Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Crossref DOI link: https://doi.org/10.1007/s11657-017-0351-2
Published Online: 2017-06-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fahrleitner-Pammer, A.
Papaioannou, N.
Gielen, E.
Feudjo Tepie, M.
Toffis, C.
Frieling, I.
Geusens, P.
Makras, P.
Boschitsch, E.
Callens, J.
Anastasilakis, A. D.
Niedhart, C.
Resch, H.
Kalouche-Khalil, L.
Hadji, P.
License valid from 2017-06-22